» Articles » PMID: 33760383

Prognostic Significance of the HFA-PEFF Score in Patients with Heart Failure with Preserved Ejection Fraction

Abstract

Aims: The HFA-PEFF score is a part of the stepwise diagnostic algorithm of heart failure with preserved ejection fraction (HFpEF). We aimed to evaluate the prognostic significance of the HFA-PEFF score on the clinical outcomes in patients with HFpEF.

Methods And Results: The Prospective mUlticenteR obServational stUdy of patIenTs with Heart Failure with preserved Ejection Fraction (PURSUIT-HFpEF) study is a prospective, multicentre, observational study in which collaborating hospitals in Osaka record clinical, echocardiographic, and outcome data of patients with acute decompensated heart failure with preserved left ventricular ejection fraction (≥50%) [UMIN-CTR ID: UMIN000021831]. Acute decompensated heart failure was diagnosed on the basis of the following criteria: (i) clinical symptoms and signs according to the Framingham Heart Study criteria; and (ii) serum N-terminal pro-B-type natriuretic peptide level of ≥400 pg/mL or brain natriuretic peptide level of ≥100 pg/mL. The HFA-PEFF score has functional, morphological, and biomarker domains. We evaluated the prognostic significance of the HFA-PEFF score (calculated based on the data at hospital discharge) on post-discharge clinical outcomes in this cohort. The primary endpoint of the present study was a composite of all-cause death and heart failure readmission. Between June 2016 and December 2019, 871 patients were enrolled from 26 hospitals (mean follow-up duration 399 ± 349 days). A total of 804 patients were finally analysed after excluding patients with scores of 0 (N = 5) and 1 (N = 15) from 824 patients with available HFA-PEFF score based on the echocardiographic and laboratory data at discharge. According to the laboratory and echocardiographic data at the time of discharge, 487 patients (59.1%) were diagnosed as HFpEF (HFA-PEFF score ≥ 5) while 317 patients (38.5%) had intermediate score. Kaplan-Meier analysis divided by the HFA-PEFF score [low, score 2-5 (N = 494) vs. high, score 6 (N = 310)] indicated that the HFA-PEFF score successfully stratified the patients for the primary endpoint (log-rank test P < 0.001). Cox proportional hazard model showed that the HFA-PEFF score was significantly associated with the primary endpoint (high score with reference to low score, adjusted hazard ratio 1.446, 95% confidence interval [1.099-1.902], P = 0.008).

Conclusion: The HFA-PEFF score at discharge was significantly associated with the post-discharge clinical outcomes in acute decompensated heart failure patients with preserved ejection fraction. This study suggested clinical usefulness of the HFA-PEFF score not only as a diagnostic tool but also a practical prognostic tool.

Citing Articles

Role and prognostic value of growth differentiation factor 15 in patient of heart failure with preserved ejection fraction: insights from the PURSUIT-HFpEF registry.

Sakamoto D, Matsuoka Y, Nakatani D, Okada K, Sunaga A, Kida H Open Heart. 2025; 12(1).

PMID: 39832941 PMC: 11784240. DOI: 10.1136/openhrt-2024-003008.


Diagnostic and prognostic value of the HFA-PEFF score for heart failure with preserved ejection fraction: a systematic review and meta-analysis.

Li X, Liang Y, Lin X Front Cardiovasc Med. 2024; 11:1389813.

PMID: 39070558 PMC: 11282482. DOI: 10.3389/fcvm.2024.1389813.


Heart Failure score and outcomes in patients with preserved ejection fraction after catheter ablation for atrial fibrillation.

Sumiyoshi H, Tasaka H, Yoshida K, Yoshino M, Kadota K ESC Heart Fail. 2024; 11(5):2986-2998.

PMID: 38822750 PMC: 11424312. DOI: 10.1002/ehf2.14876.


Discriminative Role of Invasive Left Heart Catheterization in Patients Suspected of Heart Failure With Preserved Ejection Fraction.

Choi K, Yang J, Seo J, Hong D, Youn T, Joh H J Am Heart Assoc. 2023; 12(6):e027581.

PMID: 36892042 PMC: 10111528. DOI: 10.1161/JAHA.122.027581.


Reduced functional capacity is associated with the proportion of impaired myocardial deformation assessed in heart failure patients by CMR.

Hashemi D, Doeblin P, Blum M, Weiss K, Schneider M, Beyer R Front Cardiovasc Med. 2023; 10:1038337.

PMID: 36844739 PMC: 9947709. DOI: 10.3389/fcvm.2023.1038337.


References
1.
Aaronson K, Schwartz J, Chen T, Wong K, Goin J, Mancini D . Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997; 95(12):2660-7. DOI: 10.1161/01.cir.95.12.2660. View

2.
Pitt B, Pfeffer M, Assmann S, Boineau R, Anand I, Claggett B . Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014; 370(15):1383-92. DOI: 10.1056/NEJMoa1313731. View

3.
Rahimi K, Bennett D, Conrad N, Williams T, Basu J, Dwight J . Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Fail. 2014; 2(5):440-6. DOI: 10.1016/j.jchf.2014.04.008. View

4.
Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special.... Eur Heart J. 2016; 37(27):2129-2200. DOI: 10.1093/eurheartj/ehw128. View

5.
Savji N, Meijers W, Bartz T, Bhambhani V, Cushman M, Nayor M . The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF. JACC Heart Fail. 2018; 6(8):701-709. PMC: 6076337. DOI: 10.1016/j.jchf.2018.05.018. View